Am J Kidney Dis
- LU Y, Li J, Cui Y
Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial
Fibrillation.
Am J Kidney Dis. 2026 Apr 10:S0272-6386(26)00839.
- WINKELMAYER WC, Chang TI
In Reply to: "Unmasking the Survival Benefit: Vascular Fragility and Selection
Bias in Dialysis Anticoagulation" and "Apixaban Initiation in Hemodialysis
Patients With Newly Diagnosed Atrial Fibrillation".
Am J Kidney Dis. 2026 Apr 10:S0272-6386(26)00840.
- WANG B, Huang J, Chen Z
Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis
Anticoagulation.
Am J Kidney Dis. 2026 Apr 10:S0272-6386(26)00838.
Am J Nephrol
- ELENJICKAL EJ, Mavrakanas TA
Mineralocorticoid Receptor Antagonists in Dialysis.
Am J Nephrol. 2026 Apr 15:1-27. doi: 10.1159/000551881.
- MERZKANI M, Attieh RM, Jhaveri KD, Murakami N, et al
Immunotherapy and cellular therapies for cancers in kidney transplant patients.
Am J Nephrol. 2025 Feb 20:1-23. doi: 10.1159/000544826.
Clin J Am Soc Nephrol
- NANCHEN G, Marasa M, Breno M, Martinatto C, et al
Natural History and Clinical Associations with Long-Term Outcomes in Primary C3
Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN.
Clin J Am Soc Nephrol. 2026;21:626-640.
- CHAN RJ, Arustei D, D'Gama C, Faratro R, et al
Optimizing Home Hemodialysis Vascular Access Infection Outcomes Through
Continuous Quality Improvement.
Clin J Am Soc Nephrol. 2026 Apr 10. doi: 10.2215/CJN.0000001056.
Clin Nephrol
- JIANG Q, Yu J, Zhao Y, Xiao Y, et al
Simplified nutritional and inflammatory indicators for long-term survival from
all-cause mortality in maintenance hemodialysis.
Clin Nephrol. 2026 Apr 17. doi: 10.5414/CN111855.
- SUBHASH S, Rabbani H, Dhillon N, Glass N, et al
From shelter to stroke: A mediation-proxy analysis of homelessness-associated
stroke risk in dialysis patients.
Clin Nephrol. 2026 Apr 17. doi: 10.5414/CN111835.
J Am Soc Nephrol
- DAVIS JW, Layton JB, Sahrmann JM, Nickel KB, et al
Comparative Effectiveness of Different Influenza Vaccine Formulations among
Patients Undergoing Maintenance Hemodialysis.
J Am Soc Nephrol. 2026 Apr 13. doi: 10.1681/ASN.0000001099.
J Clin Endocrinol Metab
- MOHSEN M, Yi TW, Faruque L, Ke C, et al
Combination Treatment for Management of Chronic Kidney Disease and Type 2
Diabetes: A Review and Practical Guidance.
J Clin Endocrinol Metab. 2026 Apr 13:dgag163. doi: 10.1210.
J Nephrol
- SANTOS AS, Dufour I, Morelle J, Goffin E, et al
An integrated home dialysis model facilitates transition from peritoneal dialysis
to self-care hemodialysis: evidence from a Belgian cohort.
J Nephrol. 2026 Apr 17:aajag004. doi: 10.1093.
J Ren Nutr
- WITTENDORFF PEDERSEN AE, Rousing AQ, Berg P, Christensen JF, et al
Effects of a Low-PRAL Modified New Nordic Renal Diet on Acid-Base Status in
Patients With Stage 4-5 Chronic Kidney Disease and Chronic Metabolic Acidosis.
J Ren Nutr. 2026 Apr 15:S1051-2276(26)00081-6. doi: 10.1053/j.jrn.2026.
Nephrol Dial Transplant
- IDOWU A, Lo KB, Mathew R, Navaneethan SD, et al
Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies
in Type 2 Diabetes and Chronic Kidney Disease.
Nephrol Dial Transplant. 2026 Apr 15:gfag087. doi: 10.1093.
Pediatr Nephrol
- GUTIERREZ E, Sevillano AM, Caravaca-Fontan F, Trujillo H, et al
Chronic kidney disease progression in glomerular diseases: is hematuria a key
risk factor?
Pediatr Nephrol. 2026 Apr 13. doi: 10.1007/s00467-026-07201.
- AKAY N, Aksu B, Yildirim ZY, Kardelen Al AD, et al
Baseline height Z-score as an early marker of chronic kidney disease progression:
insights from a two-year follow-up.
Pediatr Nephrol. 2026 Apr 14. doi: 10.1007/s00467-026-07282.
- CHO MH, Yang EM
Response to Letter to the Editors "Factors influencing serum uric acid levels
and their impact on cardiovascular risk in pediatric chronic kidney disease".
Pediatr Nephrol. 2026 Apr 15. doi: 10.1007/s00467-026-07255.
PLoS One
- DIAS GF, Fan C, Han M, Wang X, et al
COVID-19 in hemodialysis patients: New insights into metabolomic profile dynamics
from 60 days pre- to 60 days post-diagnosis.
PLoS One. 2026;21:e0346687.
- URENA TORRES PA, Naja M, Tran MH, Cohen-Solal M, et al
Effect of dialysate buffer practices on serum parathyroid hormone concentrations
in real-life french patients receiving hemodialysis.
PLoS One. 2026;21:e0345776.
Ren Fail
- MUTIS ALAN A, Yalin SF, Atas I, Alan O, et al
Acute hemodialysis for cancer-associated acute kidney injury: etiologies,
indications, and outcomes from a 25-year single-center experience.
Ren Fail. 2026;48:2651473.
- CHEN XY, Fan YL, Hao J
Value of different nutritional and inflammatory markers for diagnosis of
peritonitis in patients undergoing peritoneal dialysis.
Ren Fail. 2026;48:2650574.
- ZHAO A, Chen B, Lin C, Wang W, et al
Molecular mechanism of Yishen Qingzhuo oral liquid in treating chronic renal
failure via the Nrf2/HO-1-mediated ferroptosis pathway.
Ren Fail. 2026;48:2653928.
- ZHU B, Zou X, Chen Y, Lu Y, et al
A comparative study on demographics and blood biomarkers associated with chronic
kidney disease in hypertensive and non-hypertensive individuals.
Ren Fail. 2026;48:2653937.
- CHEN Y, Ren S, Yao X, Li M, et al
Benefits of physical exercises in chronic kidney disease: a systematic review and
meta-analysis of randomized controlled trials.
Ren Fail. 2026;48:2654288.
Semin Dial
- SIVARAM P, Johnson T, Mortazavi M, Anandh U, et al
Green Dialysis: A Framework for Environmentally Sustainable Renal Replacement
Therapy.
Semin Dial. 2026 Apr 14. doi: 10.1111/sdi.70028.
- FATIMA SB, Khan MA, Zafar S
Beyond Bioremediation: A Rare Case of Comamonas testosteroni Bloodstream
Infection in a Patient With Stage 5 Chronic Kidney Disease on Maintenance
Hemodialysis.
Semin Dial. 2026 Apr 13. doi: 10.1111/sdi.70026.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016